TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (Q3)Mar 31, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | -130.27%-48.86M | ---- | -8.35%161.39M | ---- | 195.91%176.1M | ---- | 1,299.11%71.08M | 40.53%59.51M | --25.21M |
Profit adjustment | ||||||||||
Investment loss (gain) | ---- | -47.71%12.18M | ---- | 330.00%23.3M | ---- | -23.39%-10.13M | ---- | -160.56%-1.06M | -1,113.46%-8.21M | --1.5M |
Attributable subsidiary (profit) loss | ---- | 234.08%18.34M | ---- | 224.55%5.49M | ---- | 34.44%-4.41M | ---- | -1,203.82%-1.71M | 35.59%-6.72M | ---155K |
Impairment and provisions: | ---- | 253.36%48.23M | ---- | 168.63%13.65M | ---- | 343.37%5.08M | ---- | -218.35%-516K | -75.90%1.15M | --3.09M |
-Impairmen of inventory (reversal) | ---- | 284.21%47.06M | ---- | 155.01%12.25M | ---- | 590.09%4.8M | ---- | 250.00%546K | -76.25%696K | --2.49M |
-Impairment of trade receivables (reversal) | ---- | -16.35%1.17M | ---- | 403.96%1.4M | ---- | -38.22%278K | ---- | -479.29%-1.06M | -75.34%450K | --607K |
Revaluation surplus: | ---- | 42.68%-948K | ---- | -38.99%-1.65M | ---- | -621.21%-1.19M | ---- | -84.89%-257K | -502.44%-165K | ---430K |
-Other fair value changes | ---- | 42.68%-948K | ---- | -38.99%-1.65M | ---- | -621.21%-1.19M | ---- | -84.89%-257K | -502.44%-165K | ---430K |
Asset sale loss (gain): | ---- | 622.73%1.27M | ---- | 100.84%176K | ---- | -12,200.00%-21.05M | ---- | -528,925.00%-21.16M | 123.08%174K | --4K |
-Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | -16,353.44%-21.29M | ---- | ---21.29M | 3,175.00%131K | ---- |
-Loss (gain) on sale of property, machinery and equipment | ---- | -73.86%46K | ---- | -26.05%176K | ---- | 453.49%238K | ---- | 3,375.00%131K | -41.89%43K | --4K |
-Loss (gain) from selling other assets | ---- | --1.23M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Depreciation and amortization: | ---- | 0.67%36.09M | ---- | 19.61%35.85M | ---- | 37.79%29.97M | ---- | 22.47%6.49M | 3.09%21.75M | --10.61M |
-Amortization of intangible assets | ---- | -52.05%280K | ---- | 97.30%584K | ---- | 0.00%296K | ---- | 1.37%74K | 0.00%296K | --148K |
-Other depreciation and amortization | ---- | 4.30%-89K | ---- | -193.94%-93K | ---- | 8.79%99K | ---- | 0.00%24K | 0.00%91K | --46K |
Financial expense | ---- | -85.22%3.29M | ---- | 33.99%22.27M | ---- | -4.26%16.62M | ---- | -16.64%3.9M | -12.13%17.36M | --8.07M |
Exchange Loss (gain) | ---- | -61.12%-6.74M | ---- | -135.35%-4.19M | ---- | 2.97%11.84M | ---- | 5.11%1.46M | 2,567.17%11.5M | --584K |
Special items | ---- | -95.88%630K | ---- | 179.46%15.28M | ---- | -191.24%-19.23M | ---- | ---- | 1,689.52%21.08M | ---- |
Operating profit before the change of operating capital | ---- | -76.62%63.49M | ---- | 47.91%271.56M | ---- | 56.36%183.6M | ---- | 217.33%58.23M | 53.18%117.42M | --48.49M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | 236.21%23.87M | ---- | 94.26%-17.53M | ---- | -3,768.32%-305.13M | ---- | -258.04%-41.91M | 109.80%8.32M | --78.08M |
Accounts receivable (increase)decrease | ---- | -322.25%-141.69M | ---- | 243.95%63.75M | ---- | 62.77%-44.29M | ---- | 26.39%-21.13M | -1,197.92%-118.95M | ---98.33M |
Accounts payable increase (decrease) | ---- | 47.48%-136.03M | ---- | -175.97%-259.01M | ---- | 174.55%340.93M | ---- | 185.57%5M | 114.11%124.18M | --22.71M |
prepayments (increase)decrease | ---- | 120.61%7.23M | ---- | -1,068.36%-35.09M | ---- | 65.15%-3M | ---- | 242.11%12.18M | -291.04%-8.62M | ---2.62M |
Special items for working capital changes | ---- | -3.88%21.77M | ---- | 512.02%22.65M | ---- | -124.43%-5.5M | ---- | -129.88%-2.61M | 398.56%22.51M | --26.16M |
Cash from business operations | 262.15%125.28M | -448.21%-161.36M | 6.97%-77.26M | -72.19%46.34M | -186.06%-83.05M | 15.02%166.61M | 29.56%96.51M | -6.99%9.76M | 191.80%144.85M | --74.49M |
Other taxs | 34.10%-6.14M | 46.96%-12.34M | -57.25%-9.32M | -176.95%-23.28M | 19.98%-5.93M | 24.40%-8.4M | 10.01%-7.41M | 77.92%-1.34M | -10.50%-11.12M | ---8.23M |
Net cash from operations | 237.60%119.14M | -853.13%-173.7M | 2.70%-86.58M | -85.42%23.06M | -199.86%-88.98M | 18.30%158.2M | 34.48%89.1M | 89.52%8.42M | 237.90%133.73M | --66.26M |
Cash flow from investment activities | ||||||||||
Interest received - investment | ---- | 98.13%7.84M | ---- | 276.69%3.96M | ---- | 64.73%1.05M | ---- | 70.34%201K | 5.45%638K | --239K |
Dividend received - investment | ---- | ---- | ---- | ---- | ---- | -87.04%540K | ---- | ---- | 309.33%4.17M | ---- |
Sale of fixed assets | 63.58%2.93M | 457.40%3.69M | 516.15%1.79M | 604.26%662K | 238.37%291K | -82.66%94K | -68.27%86K | -98.53%2K | 58.94%542K | --271K |
Purchase of fixed assets | 52.36%-22.1M | -22.38%-88.34M | 36.51%-46.39M | 11.05%-72.19M | -102.35%-73.05M | -157.16%-81.15M | -128.82%-36.1M | -54.48%-12.19M | -23.31%-31.56M | ---15.78M |
Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | --34.03M | ---- | --34.03M | ---- | ---- |
Acquisition of subsidiaries | ---6.91M | ---- | ---- | ---50.34M | ---- | ---- | ---- | ---- | ---- | ---- |
Recovery of cash from investments | ---- | 3.50%263.94M | --19.32M | 1.78%255.02M | ---- | 73.89%250.57M | ---- | 72.18%61.95M | 0.27%144.09M | --71.96M |
Cash on investment | ---- | 3.82%-243.86M | ---- | 3.96%-253.56M | ---- | -97.70%-264.02M | ---- | -71.39%-57.22M | 5.90%-133.54M | ---66.77M |
Other items in the investment business | -33.37%3.77M | ---1.23M | 956.21%5.65M | ---- | -101.80%-660K | ---- | --36.7M | ---- | ---- | ---- |
Net cash from investment operations | -13.68%-22.31M | 50.22%-57.96M | 73.27%-19.62M | -97.73%-116.44M | -10,787.34%-73.42M | -276.05%-58.89M | 106.82%687K | 631.65%26.78M | 38.49%-15.66M | ---10.08M |
Net cash before financing | 191.17%96.83M | -148.09%-231.66M | 34.60%-106.21M | -194.02%-93.38M | -280.87%-162.4M | -15.89%99.31M | 59.82%89.79M | 6,046.45%35.2M | 736.24%118.07M | --56.18M |
Cash flow from financing activities | ||||||||||
New borrowing | ---- | -29.88%346.35M | ---- | -23.20%493.95M | ---- | 6.41%643.13M | ---- | -12.04%132.91M | 2.91%604.4M | --310.94M |
Refund | ---- | 41.26%-348.83M | ---- | -7.52%-593.91M | ---- | 13.48%-552.36M | ---- | 44.01%-89.37M | -14.54%-638.45M | ---318.7M |
Issuing shares | ---- | 66.12%100.17M | 70.95%99.21M | -85.29%60.3M | --58.03M | --409.85M | ---- | --7.86M | ---- | ---- |
Interest paid - financing | ---- | 30.44%-9.41M | ---- | 34.30%-13.52M | ---- | -27.39%-20.58M | ---- | 9.05%-3.67M | 21.53%-16.16M | ---6.04M |
Dividends paid - financing | ---- | -4.68%-36.69M | ---- | -133.67%-35.05M | ---- | ---15M | ---15M | ---15M | ---- | ---- |
Issuance expenses and redemption of securities expenses | ---- | 57.50%-963K | ---- | 85.39%-2.27M | ---- | ---15.51M | ---- | ---- | ---- | ---- |
Pledged bank deposit (increase) decrease | ---- | 449.44%16.83M | ---- | 70.11%-4.82M | ---- | -805.39%-16.11M | ---- | -8,457.95%-7.36M | 355.89%2.28M | ---3.24M |
Other items of the financing business | 92.91%-4.44M | ---- | -3.02%-62.59M | ---- | -1,386.78%-60.75M | ---28.43M | ---4.09M | ---28.43M | ---- | ---- |
Net cash from financing operations | -112.12%-4.44M | 158.71%61.1M | 1,447.81%36.62M | -126.05%-104.07M | 85.76%-2.72M | 892.24%399.55M | -5.40%-19.09M | 69.23%-3.98M | -766.40%-50.43M | ---18.11M |
Effect of rate | -90.13%-1.64M | 122.07%183K | 13.21%-861K | -2.73%-829K | -205.31%-992K | -115.41%-807K | 153.07%942K | -210.83%-1.49M | 689.09%5.24M | ---1.78M |
Net Cash | 232.77%92.39M | 13.62%-170.56M | 57.86%-69.59M | -139.58%-197.45M | -333.54%-165.12M | 637.57%498.86M | 85.70%70.7M | 330.73%31.22M | 211.87%67.64M | --38.07M |
Begining period cash | -36.51%296.34M | -29.82%466.71M | -29.82%466.71M | 298.35%664.99M | 298.35%664.99M | 77.47%166.94M | 77.47%166.94M | 77.47%166.94M | 28.39%94.06M | --94.06M |
Cash at the end | -2.32%387.09M | -36.51%296.34M | -20.57%396.27M | -29.82%466.71M | 109.10%498.88M | 298.35%664.99M | 83.01%238.58M | 140.19%196.67M | 77.47%166.94M | --130.36M |
Cash balance analysis | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | -- | Unqualified Opinion | -- |
Auditor | -- | KPMG | -- | KPMG | -- | KPMG | -- | -- | KPMG | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.